RT Journal Article
SR Electronic
T1 The Clinical Impact of Other Primary Cancer in Patients Who Received Curative Treatment for Esophageal Cancer
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 5635
OP 5641
DO 10.21873/anticanres.16072
VO 42
IS 11
A1 TORU AOYAMA
A1 YUKIO MAEZAWA
A1 KENTARO HARA
A1 MIWHA JU
A1 KEISUKE KOMORI
A1 HIROSHI TAMAGAWA
A1 AYAKO TAMAGAWA
A1 KEISUKE KAZAMA
A1 SHO SAWAZAKI
A1 ITARU HASHIMOTO
A1 KAZUKI KANO
A1 HARUHIKO CHO
A1 JUNYA MORITA
A1 KENKI SEGAMI
A1 TETSUSHI ISHIGURO
A1 TSUTOMU SATO
A1 TAKASHI OSHIMA
A1 NORIO YUKAWA
A1 YASUSHI RINO
YR 2022
UL http://ar.iiarjournals.org/content/42/11/5635.abstract
AB Background/Aim: The present study evaluated the clinical impact of other metachronous or synchronous primary cancer (OPC) in patients who received curative treatment for esophageal cancer. Patients and Methods: The present study included 168 patients who underwent curative treatment for esophageal cancer between 2005 and 2018. Prognosis and differences between the OPC status (metachronous/synchronous) and clinic pathological parameters was analyzed. Results: A total of 168 patients were included in this study. Forty patients were diagnosed with metachronous/synchronous OPC. When comparing the clinicopathological factors between the patients with and without OPC, the patients’ background and postoperative clinical courses were very similar between the two groups. The 3- and 5-year overall survival rates in patients with esophageal cancer with OPC were 66.0% and 54.5%, respectively, while those in patients without OPC were 50.1% and 41.4%, respectively. There was no statistically significant difference in these rates (p=0.156). The OPC status was not included in the final multivariate analysis model. Conclusion: The OPC status was not found to be a prognostic factor for patients who received curative treatment for esophageal cancer. Therefore, it is not necessary to avoid performing curative treatment for esophageal cancer because of a patient’s OPC status.